{"schema_version":"alpha-company-profile-public-v2","slug":"novavax-inc","canonical_url":"https://registry.alpha.ac/companies/novavax-inc","published_on":"2026-09-14T14:36:15.725755+00:00","last_reviewed_on":"2026-09-14T14:36:15.725755+00:00","identity":{"legal_name":"NOVAVAX INC","display_name":"NOVAVAX INC","headline":"Canonical company identity and public leadership record.","description":"Alpha's canonical identity and public leadership record for NOVAVAX INC.","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001000694","logo":"https://cdn.brandfetch.io/ticker/nvax/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/nvax/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"NOVAVAX INC logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-14T14:36:15.725755+00:00"},"security_listings":[{"ticker":"NVAX","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"NOVAVAX INC","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/novavax-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-14T14:36:15.725755+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":26,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":26,"corroborated_claims":0,"sources":4,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-14T14:36:15.725755+00:00","observed_at":"2026-09-14T14:36:15.725755+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"novavax-inc","canonical_url":"https://registry.alpha.ac/companies/novavax-inc"},"publication":{"published_at":"2026-09-14T14:36:15.725755+00:00","last_reviewed_at":"2026-09-14T14:36:15.725755+00:00","as_of":"2026-09-14T14:36:15.725755+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/novavax-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/novavax-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/novavax-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"novavax-inc","canonical_url":"https://registry.alpha.ac/companies/novavax-inc","as_of":"2026-09-14T14:36:15.725755+00:00","last_reviewed_at":"2026-09-14T14:36:15.725755+00:00","identity":{"legal_name":"NOVAVAX INC","display_name":"NOVAVAX INC","description":null,"jurisdiction":null,"country":"US","sector":null,"industry":null,"website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001000694","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"NVAX","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"0dc713be-8417-4bb2-8dae-baf3a601199b","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-15","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"david-mott-nvax","display_name":"David Mott","role_category":"director","title":"Chairman of the Board","committee":null,"is_board_chair":true,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"alderya-therapeutics-nvax","display_name":"Alderya Therapeutics","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A nvax-20260427.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_proxy","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-02T01:29:30.958071+00:00"},"headshot_url":null},{"person_slug":"amicus-therapeutics-nvax","display_name":"Amicus Therapeutics","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A nvax-20260427.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_proxy","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-02T01:29:30.958071+00:00"},"headshot_url":null},{"person_slug":"auravax-therapeutics-nvax","display_name":"AuraVax Therapeutics","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A nvax-20260427.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_proxy","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-02T01:29:30.958071+00:00"},"headshot_url":null},{"person_slug":"brii-biosciences-nvax","display_name":"Brii Biosciences","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A nvax-20260427.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_proxy","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-02T01:29:30.958071+00:00"},"headshot_url":null},{"person_slug":"charles-w-newton-nvax","display_name":"Charles W. Newton","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A nvax-20260427.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_proxy","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-02T01:29:30.958071+00:00"},"headshot_url":null},{"person_slug":"gregg-h-alton","display_name":"Gregg H. Alton","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"john-c-jacobs","display_name":"John C. Jacobs","role_category":"director","title":"President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"john-w-shiver","display_name":"John W. Shiver","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"margaret-g-mcglynn-novavax-inc","display_name":"Margaret G. McGlynn","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"maryland-life-sciences-advisory-nvax","display_name":"Maryland Life Sciences Advisory","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A nvax-20260427.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_proxy","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-02T01:29:30.958071+00:00"},"headshot_url":null},{"person_slug":"opus-genetics-nvax","display_name":"Opus Genetics","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2010-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A nvax-20260427.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_proxy","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-02T01:29:30.958071+00:00"},"headshot_url":null},{"person_slug":"rachel-k-king","display_name":"Rachel K. King","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"richard-h-douglas","display_name":"Richard H. Douglas","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"richard-j-rodgers","display_name":"Richard J. Rodgers","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null}],"executives":[{"person_slug":"elaine-o-hara","display_name":"Elaine O'Hara","role_category":"executive","title":"Executive Vice President, Chief Strategy Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"james-p-kelly","display_name":"James P. Kelly","role_category":"executive","title":"Executive Vice President, Chief Financial Officer and Treasurer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"jeffrey-d-kelly","display_name":"Jeffrey D. Kelly","role_category":"executive","title":"Named Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"NVAX DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_filing","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-05-05T00:04:25.73024+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/9ba446ec-3601-4240-a355-90f699171999.jpg"},{"person_slug":"john-c-jacobs","display_name":"John C. Jacobs","role_category":"executive","title":"President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"john-trizzino","display_name":"John Trizzino","role_category":"executive","title":"Named Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"NVAX DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_filing","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-05-05T00:04:27.352145+00:00"},"headshot_url":null},{"person_slug":"mark-j-casey","display_name":"Mark J. Casey","role_category":"executive","title":"Executive Vice President, Chief Legal Officer and Corporate Secretary","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001628280-26-027328","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_def_14a","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-09-12T16:15:04.417067+00:00"},"headshot_url":null},{"person_slug":"michael-casey","display_name":"Michael Casey","role_category":"executive","title":"Executive Vice President, Chief Legal Officer and Corporate Secretary","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"NVAX DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_filing","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-05-05T00:04:26.78667+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/bf0d6275-0fa8-4a3f-a6fe-10f2a4dbd882.jpg"},{"person_slug":"ruxandra-draghia-akli","display_name":"Ruxandra Draghia-Akli","role_category":"executive","title":"Named Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"NVAX DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm","source_type":"sec_filing","published_at":"2026-04-27T00:00:00+00:00","effective_date":"2026-04-27","last_checked_at":"2026-05-05T00:04:27.940796+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/novavax-inc#profile","url":"https://registry.alpha.ac/companies/novavax-inc","dateModified":"2026-09-14T14:36:15.725755+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/novavax-inc#organization","legalName":"NOVAVAX INC","name":"NOVAVAX INC","url":"https://registry.alpha.ac/companies/novavax-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Chairman of the Board","member":{"@type":"Person","name":"David Mott","url":"https://registry.alpha.ac/people/david-mott-nvax"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Alderya Therapeutics","url":"https://registry.alpha.ac/people/alderya-therapeutics-nvax"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Amicus Therapeutics","url":"https://registry.alpha.ac/people/amicus-therapeutics-nvax"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","member":{"@type":"Person","name":"AuraVax Therapeutics","url":"https://registry.alpha.ac/people/auravax-therapeutics-nvax"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Brii Biosciences","url":"https://registry.alpha.ac/people/brii-biosciences-nvax"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","member":{"@type":"Person","name":"Charles W. Newton","url":"https://registry.alpha.ac/people/charles-w-newton-nvax"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Gregg H. Alton","url":"https://registry.alpha.ac/people/gregg-h-alton"}},{"@type":"OrganizationRole","roleName":"President and Chief Executive Officer","member":{"@type":"Person","name":"John C. Jacobs","url":"https://registry.alpha.ac/people/john-c-jacobs"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"John W. Shiver","url":"https://registry.alpha.ac/people/john-w-shiver"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Margaret G. McGlynn","url":"https://registry.alpha.ac/people/margaret-g-mcglynn-novavax-inc"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","member":{"@type":"Person","name":"Maryland Life Sciences Advisory","url":"https://registry.alpha.ac/people/maryland-life-sciences-advisory-nvax"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2010-01-01","member":{"@type":"Person","name":"Opus Genetics","url":"https://registry.alpha.ac/people/opus-genetics-nvax"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Rachel K. King","url":"https://registry.alpha.ac/people/rachel-k-king"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Richard H. Douglas","url":"https://registry.alpha.ac/people/richard-h-douglas"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Richard J. Rodgers","url":"https://registry.alpha.ac/people/richard-j-rodgers"}},{"@type":"OrganizationRole","roleName":"Executive Vice President, Chief Strategy Officer","member":{"@type":"Person","name":"Elaine O'Hara","url":"https://registry.alpha.ac/people/elaine-o-hara"}},{"@type":"OrganizationRole","roleName":"Executive Vice President, Chief Financial Officer and Treasurer","member":{"@type":"Person","name":"James P. Kelly","url":"https://registry.alpha.ac/people/james-p-kelly"}},{"@type":"OrganizationRole","roleName":"Named Executive Officer","startDate":"2026-04-27","member":{"@type":"Person","name":"Jeffrey D. Kelly","url":"https://registry.alpha.ac/people/jeffrey-d-kelly"}},{"@type":"OrganizationRole","roleName":"President and Chief Executive Officer","member":{"@type":"Person","name":"John C. Jacobs","url":"https://registry.alpha.ac/people/john-c-jacobs"}},{"@type":"OrganizationRole","roleName":"Named Executive Officer","startDate":"2026-04-27","member":{"@type":"Person","name":"John Trizzino","url":"https://registry.alpha.ac/people/john-trizzino"}},{"@type":"OrganizationRole","roleName":"Executive Vice President, Chief Legal Officer and Corporate Secretary","member":{"@type":"Person","name":"Mark J. Casey","url":"https://registry.alpha.ac/people/mark-j-casey"}},{"@type":"OrganizationRole","roleName":"Executive Vice President, Chief Legal Officer and Corporate Secretary","startDate":"2026-04-27","member":{"@type":"Person","name":"Michael Casey","url":"https://registry.alpha.ac/people/michael-casey"}},{"@type":"OrganizationRole","roleName":"Named Executive Officer","startDate":"2026-04-27","member":{"@type":"Person","name":"Ruxandra Draghia-Akli","url":"https://registry.alpha.ac/people/ruxandra-draghia-akli"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/novavax-inc"},"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"}},"canonical_source":"aegis_canonical"}